Roivant and Moderna, two of the most highly-funded private biotech companies, appear to engaged in a proxy war over medical technology and headed for a showdown.
from Forbes Real Time https://www.forbes.com/sites/nathanvardi/2017/10/02/roivant-makes-116-million-investment-in-arbutus-backing-battle-with-moderna/
via IFTTT
No comments:
Post a Comment